These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 24472072)
1. Plasminogen activator inhibitor-1 4G/5G polymorphism and ischemic stroke risk: a meta-analysis in Chinese population. Cao Y; Chen W; Qian Y; Zeng Y; Liu W Int J Neurosci; 2014 Dec; 124(12):874-81. PubMed ID: 24472072 [TBL] [Abstract][Full Text] [Related]
2. ATP-binding cassette transporter A1 R219K polymorphism and ischemic stroke risk in the Chinese population: a meta-analysis. Hou R; Zhu X; Pan X; Guo R; Ma T; Xu X J Neurol Sci; 2014 Jan; 336(1-2):57-61. PubMed ID: 24157307 [TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor-1 4G/5G gene polymorphism and coronary artery disease in the Chinese Han population: a meta-analysis. Li YY PLoS One; 2012; 7(4):e33511. PubMed ID: 22496752 [TBL] [Abstract][Full Text] [Related]
4. Association Between Plasminogen Activator Inhibitor-1 Genetic Polymorphisms and Stroke Susceptibility. Hu X; Zan X; Xie Z; Li Y; Lin S; Li H; You C Mol Neurobiol; 2017 Jan; 54(1):328-341. PubMed ID: 26742513 [TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of genetic studies from journals published in China of ischemic stroke in the Han Chinese population. Xu X; Li J; Sheng W; Liu L Cerebrovasc Dis; 2008; 26(1):48-62. PubMed ID: 18511872 [TBL] [Abstract][Full Text] [Related]
6. 4G/5G promoter polymorphism of plasminogen activator inhibitor-1, lipid profiles, and ischemic stroke. Chen CH; Eng HL; Chang CJ; Tsai TT; Lai ML; Chen HY; Liu CJ; Lin TM J Lab Clin Med; 2003 Aug; 142(2):100-5. PubMed ID: 12960956 [TBL] [Abstract][Full Text] [Related]
7. Global fibrinolytic activity, PAI-1 level, and 4G/5G polymorphism in Thai children with arterial ischemic stroke. Natesirinilkul R; Sasanakul W; Chuansumrit A; Kadegasem P; Visudtibhan A; Wongwerawattanakoon P; Sirachainan N J Stroke Cerebrovasc Dis; 2014; 23(10):2566-2572. PubMed ID: 25284719 [TBL] [Abstract][Full Text] [Related]
8. The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study. van Goor ML; Gómez García E; Leebeek F; Brouwers GJ; Koudstaal P; Dippel D Thromb Haemost; 2005 Jan; 93(1):92-6. PubMed ID: 15630497 [TBL] [Abstract][Full Text] [Related]
9. The -675 4G/5G polymorphism in plasminogen activator inhibitor-1 gene is associated with risk of asthma: a meta-analysis. Nie W; Li B; Xiu QY PLoS One; 2012; 7(3):e34385. PubMed ID: 22479620 [TBL] [Abstract][Full Text] [Related]
10. Association between PAI-1 4G/5G polymorphism and diabetic nephropathy: a meta-analysis in the Chinese population. Gao WF; Guo YB; Bai Y; Ding XY; Yan YJ; Wu ZQ Int Urol Nephrol; 2016 Sep; 48(9):1483-9. PubMed ID: 27272255 [TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case-control studies based on independent cohorts. Wiklund PG; Nilsson L; Ardnor SN; Eriksson P; Johansson L; Stegmayr B; Hamsten A; Holmberg D; Asplund K Stroke; 2005 Aug; 36(8):1661-5. PubMed ID: 16020771 [TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor-1 gene polymorphism 4G/4G genotype and lupus nephritis in Chinese patients. Wang AY; Poon P; Lai FM; Yu L; Choi PC; Lui SF; Li PK Kidney Int; 2001 Apr; 59(4):1520-8. PubMed ID: 11260416 [TBL] [Abstract][Full Text] [Related]
13. The Role of PAI-1 4G/5G Promoter Polymorphism and Its Levels in the Development of Ischemic Stroke in Young Indian Population. Akhter MS; Biswas A; Abdullah SM; Behari M; Saxena R Clin Appl Thromb Hemost; 2017 Nov; 23(8):1071-1076. PubMed ID: 28460568 [TBL] [Abstract][Full Text] [Related]
14. Association of PAI-1 4G/5G Polymorphism with Ischemic Stroke in Chinese Patients with Type 2 Diabetes Mellitus. Li G; Liu Y; Li X; Ning Z; Sun Z; Zhang M; Lu Y; Wu L; Wang L Genet Test Mol Biomarkers; 2018 Sep; 22(9):554-560. PubMed ID: 30160528 [TBL] [Abstract][Full Text] [Related]
15. PAI-1 -675 4G/5G polymorphism in association with diabetes and diabetic complications susceptibility: a meta-analysis study. Xu K; Liu X; Yang F; Cui D; Shi Y; Shen C; Tang W; Yang T PLoS One; 2013; 8(11):e79150. PubMed ID: 24223897 [TBL] [Abstract][Full Text] [Related]
17. 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and insertion/deletion polymorphism of the tissue-type plasminogen activator gene in atherothrombotic stroke. Bang CO; Park HK; Ahn MY; Shin HK; Hwang KY; Hong SY Cerebrovasc Dis; 2001; 11(4):294-9. PubMed ID: 11385207 [TBL] [Abstract][Full Text] [Related]
18. Association between the 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene and sudden sensorineural hearing loss in Caucasian population: a meta-analysis. Wei Z; Chang K; Fan C Eur Arch Otorhinolaryngol; 2021 Jul; 278(7):2203-2208. PubMed ID: 32901365 [TBL] [Abstract][Full Text] [Related]
19. Association between plasminogen activator inhibitor-1 -675 4G/5G polymorphism and sepsis: a meta-analysis. Li L; Nie W; Zhou H; Yuan W; Li W; Huang W PLoS One; 2013; 8(1):e54883. PubMed ID: 23382992 [TBL] [Abstract][Full Text] [Related]
20. [Association of plasminogen activator inhibitor-1 gene 4G/5G polymorphism and coronary heart disease in Chinese patients]. Guan L; Ji X; Wang J; Zhang A; Zhang Y; Zhao L Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Oct; 19(5):393-6. PubMed ID: 12362314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]